Hematologic Inflammation Indices for Differentiating between Brucella, Pyogenic, and Tuberculous Spondylodiscitis

Infectious spondylodiscitis is a life-threatening disease and has some challenges in terms of diagnostic, differentiative, and therapeutic processes. Therefore, rapid and effective management of infectious spondylodiscitis is necessary. Hematological inflammation indices (HIIs) such as the neutrophil/lymphocyte ratio and aggregate index of systemic inflammation are derived from blood cells and used as diagnostic, prognostic, predictive, and treatment monitoring indicators. This study aimed to evaluate HIIs for discriminating between infectious spondylodiscitis pathogens. This retrospective comparative study included 116 patients with infectious spondylodiscitis. According to the responsible infectious pathogens, three types of infectious spondylodiscitis were defined: <i>Brucella</i> (n = 51), pyogenic (n = 43), and tuberculous (n = 22). The HIIs were derived from baseline complete blood counts. The three types of infectious spondylodiscitis were statistically compared for the HII scores. We found that the <i>Brucella</i> group had significantly lower HII scores than the pyogenic group (<i>p</i> < 0.05). Also, the <i>Brucella</i> group had significantly lower HII scores than the tuberculous group (<i>p</i> < 0.05). However, no significant differences were found between the pyogenic and tuberculous groups regarding HIIs (<i>p</i> > 0.05). In conclusion, the HIIs may be considered in the differentiation between <i>Brucella</i> spondylodiscitis and other types of infectious spondylodiscitis.